ENO2 and cancer: A challenge ahead will be to gain insight into mechanisms of NSE repression in normal and cancer cells where the NSE control appears to be compromised, potentially altering ATM expression and DDR in the haplotype-dependent manner (Fig. 2 and S8b,c).